Benzyl 7-bromospiro[indoline-3,4'-piperidine]-1'-carboxylate

Catalog No.: 
ACASJH920
CAS No.: 
1243461-51-9
Molecular Formula: 
C20H21BrN2O2
Molecular Weight: 
401.30
Benzyl 7-bromospiro[indoline-3,4'-piperidine]-1'-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%
1g98%
5g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 7-bromospiro[indoline-3,4'-piperidine]-1'-carboxylate
IUPAC Namebenzyl 7-bromospiro[indoline-3,4'-piperidine]-1'-carboxylate
MDL No.MFCD15071690
Molecular FormulaC20H21BrN2O2
Molecular Weight401.30
SMILESO=C(N1CCC2(CC1)CNC3=C2C=CC=C3Br)OCC4=CC=CC=C4
InChI KeyKZKLFTYTLKBZLX-UHFFFAOYSA-N
SynonymBENZYL 7-BROMOSPIRO[INDOLINE-3,4'-PIPERIDINE]-1'-CARBOXYLATE;Benzyl 7-bromo-1,2-dihydrospiro[indole-3,4'-piperidine]-1'-carboxylate;Spiro[3H-indole-3,4'-piperidine]-1'-carboxylic acid, 7-bromo-1,2-dihydro-, phenylmethyl ester
CAS No.1243461-51-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACASJH920 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACASJH920 route product structure diagram
    ACASJH9201243461-51-9
Inquiry

2. ACASJH920 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACASJH920 route product structure diagram
    ACASJH9201243461-51-9
Inquiry

3. ACASJH920 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACASJH920 route product structure diagram
    ACASJH9201243461-51-9
Inquiry

Comments (0)